nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—blood plasma—acquired immunodeficiency syndrome	0.0386	0.125	CbGeAlD
Amlexanox—IL3—lymphoid tissue—acquired immunodeficiency syndrome	0.015	0.0487	CbGeAlD
Amlexanox—Aphthous stomatitis—Indinavir—acquired immunodeficiency syndrome	0.0149	0.0389	CcSEcCtD
Amlexanox—FGF1—nerve—acquired immunodeficiency syndrome	0.0149	0.0483	CbGeAlD
Amlexanox—IL3—blood—acquired immunodeficiency syndrome	0.0141	0.0458	CbGeAlD
Amlexanox—IL3—bone marrow—acquired immunodeficiency syndrome	0.0137	0.0443	CbGeAlD
Amlexanox—Aphthous stomatitis—Delavirdine—acquired immunodeficiency syndrome	0.0135	0.0352	CcSEcCtD
Amlexanox—FGF1—endothelium—acquired immunodeficiency syndrome	0.0127	0.0411	CbGeAlD
Amlexanox—Aphthous stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0313	CcSEcCtD
Amlexanox—Throat sore—Abacavir—acquired immunodeficiency syndrome	0.0118	0.0308	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Abacavir—acquired immunodeficiency syndrome	0.0117	0.0306	CcSEcCtD
Amlexanox—FGF1—blood plasma—acquired immunodeficiency syndrome	0.0113	0.0365	CbGeAlD
Amlexanox—Oropharyngeal pain—Abacavir—acquired immunodeficiency syndrome	0.00938	0.0244	CcSEcCtD
Amlexanox—S100A13—skin of body—acquired immunodeficiency syndrome	0.00881	0.0285	CbGeAlD
Amlexanox—IL3—lymph node—acquired immunodeficiency syndrome	0.00848	0.0275	CbGeAlD
Amlexanox—Mouth ulceration—Nevirapine—acquired immunodeficiency syndrome	0.00811	0.0211	CcSEcCtD
Amlexanox—Mouth ulceration—Nelfinavir—acquired immunodeficiency syndrome	0.00786	0.0205	CcSEcCtD
Amlexanox—Mouth ulceration—Stavudine—acquired immunodeficiency syndrome	0.00783	0.0204	CcSEcCtD
Amlexanox—Mouth ulceration—Abacavir—acquired immunodeficiency syndrome	0.00772	0.0201	CcSEcCtD
Amlexanox—Throat sore—Lamivudine—acquired immunodeficiency syndrome	0.00746	0.0194	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00739	0.0192	CcSEcCtD
Amlexanox—Liver function test abnormal—Amprenavir—acquired immunodeficiency syndrome	0.00733	0.0191	CcSEcCtD
Amlexanox—S100A13—digestive system—acquired immunodeficiency syndrome	0.00705	0.0228	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—acquired immunodeficiency syndrome	0.00704	0.0228	CbGeAlD
Amlexanox—S100A12—digestive system—acquired immunodeficiency syndrome	0.00695	0.0225	CbGeAlD
Amlexanox—Mouth ulceration—Zidovudine—acquired immunodeficiency syndrome	0.00681	0.0177	CcSEcCtD
Amlexanox—S100A12—blood—acquired immunodeficiency syndrome	0.00662	0.0214	CbGeAlD
Amlexanox—S100A13—Indinavir—Nelfinavir—acquired immunodeficiency syndrome	0.00656	0.389	CbGdCrCtD
Amlexanox—Oropharyngeal pain—Ritonavir—acquired immunodeficiency syndrome	0.00644	0.0168	CcSEcCtD
Amlexanox—S100A12—bone marrow—acquired immunodeficiency syndrome	0.00641	0.0207	CbGeAlD
Amlexanox—FGF1—retina—acquired immunodeficiency syndrome	0.00618	0.02	CbGeAlD
Amlexanox—S100A12—vagina—acquired immunodeficiency syndrome	0.00614	0.0199	CbGeAlD
Amlexanox—Liver function test abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00601	0.0157	CcSEcCtD
Amlexanox—Oropharyngeal pain—Lamivudine—acquired immunodeficiency syndrome	0.00591	0.0154	CcSEcCtD
Amlexanox—S100A13—lung—acquired immunodeficiency syndrome	0.00588	0.0191	CbGeAlD
Amlexanox—Liver function test abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00582	0.0152	CcSEcCtD
Amlexanox—S100A12—lung—acquired immunodeficiency syndrome	0.0058	0.0188	CbGeAlD
Amlexanox—Mouth ulceration—Delavirdine—acquired immunodeficiency syndrome	0.00572	0.0149	CcSEcCtD
Amlexanox—Liver function test abnormal—Abacavir—acquired immunodeficiency syndrome	0.00572	0.0149	CcSEcCtD
Amlexanox—S100A13—nervous system—acquired immunodeficiency syndrome	0.00545	0.0176	CbGeAlD
Amlexanox—FGF1—skin of body—acquired immunodeficiency syndrome	0.00542	0.0176	CbGeAlD
Amlexanox—S100A13—Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.00535	0.317	CbGdCrCtD
Amlexanox—Mouth ulceration—Ritonavir—acquired immunodeficiency syndrome	0.00529	0.0138	CcSEcCtD
Amlexanox—S100A13—central nervous system—acquired immunodeficiency syndrome	0.00525	0.017	CbGeAlD
Amlexanox—Mouth ulceration—Saquinavir—acquired immunodeficiency syndrome	0.00509	0.0133	CcSEcCtD
Amlexanox—S100A13—Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.00497	0.295	CbGdCrCtD
Amlexanox—Mouth ulceration—Lamivudine—acquired immunodeficiency syndrome	0.00486	0.0127	CcSEcCtD
Amlexanox—Stomatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00474	0.0123	CcSEcCtD
Amlexanox—Stomatitis—Stavudine—acquired immunodeficiency syndrome	0.00472	0.0123	CcSEcCtD
Amlexanox—Stomatitis—Abacavir—acquired immunodeficiency syndrome	0.00465	0.0121	CcSEcCtD
Amlexanox—FGF1—lymphoid tissue—acquired immunodeficiency syndrome	0.00439	0.0142	CbGeAlD
Amlexanox—FGF1—digestive system—acquired immunodeficiency syndrome	0.00434	0.014	CbGeAlD
Amlexanox—S100A13—brain—acquired immunodeficiency syndrome	0.00416	0.0135	CbGeAlD
Amlexanox—FGF1—blood—acquired immunodeficiency syndrome	0.00413	0.0134	CbGeAlD
Amlexanox—S100A12—brain—acquired immunodeficiency syndrome	0.00411	0.0133	CbGeAlD
Amlexanox—Stomatitis—Zidovudine—acquired immunodeficiency syndrome	0.00411	0.0107	CcSEcCtD
Amlexanox—PDE4C—nervous system—acquired immunodeficiency syndrome	0.00407	0.0132	CbGeAlD
Amlexanox—S100A13—lymph node—acquired immunodeficiency syndrome	0.00402	0.013	CbGeAlD
Amlexanox—FGF1—spinal cord—acquired immunodeficiency syndrome	0.00398	0.0129	CbGeAlD
Amlexanox—S100A12—lymph node—acquired immunodeficiency syndrome	0.00397	0.0129	CbGeAlD
Amlexanox—Liver function test abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.0102	CcSEcCtD
Amlexanox—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.00392	0.0127	CbGeAlD
Amlexanox—PDE4D—lung—acquired immunodeficiency syndrome	0.00387	0.0125	CbGeAlD
Amlexanox—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00383	0.00997	CcSEcCtD
Amlexanox—Liver function test abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00378	0.00983	CcSEcCtD
Amlexanox—FGF1—lung—acquired immunodeficiency syndrome	0.00362	0.0117	CbGeAlD
Amlexanox—Liver function test abnormal—Lamivudine—acquired immunodeficiency syndrome	0.0036	0.00938	CcSEcCtD
Amlexanox—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00351	0.00913	CcSEcCtD
Amlexanox—Stomatitis—Delavirdine—acquired immunodeficiency syndrome	0.00345	0.00899	CcSEcCtD
Amlexanox—PDE4A—lung—acquired immunodeficiency syndrome	0.00343	0.0111	CbGeAlD
Amlexanox—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00337	0.00878	CcSEcCtD
Amlexanox—FGF1—nervous system—acquired immunodeficiency syndrome	0.00335	0.0109	CbGeAlD
Amlexanox—FGF1—central nervous system—acquired immunodeficiency syndrome	0.00323	0.0105	CbGeAlD
Amlexanox—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.0032	0.00833	CcSEcCtD
Amlexanox—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.00319	0.00831	CcSEcCtD
Amlexanox—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00314	0.00818	CcSEcCtD
Amlexanox—PDE4C—brain—acquired immunodeficiency syndrome	0.00311	0.0101	CbGeAlD
Amlexanox—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.00307	0.008	CcSEcCtD
Amlexanox—Pain—Didanosine—acquired immunodeficiency syndrome	0.00304	0.00793	CcSEcCtD
Amlexanox—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00303	0.00789	CcSEcCtD
Amlexanox—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00299	0.00778	CcSEcCtD
Amlexanox—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.00293	0.00763	CcSEcCtD
Amlexanox—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00287	0.00749	CcSEcCtD
Amlexanox—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00725	CcSEcCtD
Amlexanox—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00278	0.00723	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00276	0.0072	CcSEcCtD
Amlexanox—PDE4D—brain—acquired immunodeficiency syndrome	0.00274	0.00888	CbGeAlD
Amlexanox—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00274	0.00713	CcSEcCtD
Amlexanox—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00712	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00268	0.00697	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00267	0.00695	CcSEcCtD
Amlexanox—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00265	0.00691	CcSEcCtD
Amlexanox—PDE4D—lymph node—acquired immunodeficiency syndrome	0.00265	0.00858	CbGeAlD
Amlexanox—Pain—Stavudine—acquired immunodeficiency syndrome	0.00264	0.00688	CcSEcCtD
Amlexanox—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00263	0.00686	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00263	0.00685	CcSEcCtD
Amlexanox—Pain—Abacavir—acquired immunodeficiency syndrome	0.0026	0.00678	CcSEcCtD
Amlexanox—FGF1—brain—acquired immunodeficiency syndrome	0.00256	0.0083	CbGeAlD
Amlexanox—FGF1—lymph node—acquired immunodeficiency syndrome	0.00248	0.00802	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00248	0.00802	CbGeAlD
Amlexanox—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00245	0.00638	CcSEcCtD
Amlexanox—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00245	0.00637	CcSEcCtD
Amlexanox—PDE4A—brain—acquired immunodeficiency syndrome	0.00243	0.00786	CbGeAlD
Amlexanox—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00628	CcSEcCtD
Amlexanox—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00234	0.00759	CbGeAlD
Amlexanox—PDE4B—blood—acquired immunodeficiency syndrome	0.00233	0.00755	CbGeAlD
Amlexanox—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00232	0.00604	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00232	0.00604	CcSEcCtD
Amlexanox—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00231	0.00603	CcSEcCtD
Amlexanox—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0023	0.00598	CcSEcCtD
Amlexanox—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.00226	0.0073	CbGeAlD
Amlexanox—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.00225	0.00727	CbGeAlD
Amlexanox—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00584	CcSEcCtD
Amlexanox—Headache—Didanosine—acquired immunodeficiency syndrome	0.00223	0.00581	CcSEcCtD
Amlexanox—PDE4B—vagina—acquired immunodeficiency syndrome	0.00216	0.007	CbGeAlD
Amlexanox—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00216	0.00562	CcSEcCtD
Amlexanox—Pain—Indinavir—acquired immunodeficiency syndrome	0.00214	0.00556	CcSEcCtD
Amlexanox—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00552	CcSEcCtD
Amlexanox—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00211	0.00551	CcSEcCtD
Amlexanox—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00533	CcSEcCtD
Amlexanox—PDE4B—lung—acquired immunodeficiency syndrome	0.00204	0.00662	CbGeAlD
Amlexanox—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00204	0.00531	CcSEcCtD
Amlexanox—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00528	CcSEcCtD
Amlexanox—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00202	0.00526	CcSEcCtD
Amlexanox—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00201	0.00522	CcSEcCtD
Amlexanox—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00513	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00195	0.00508	CcSEcCtD
Amlexanox—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00194	0.00506	CcSEcCtD
Amlexanox—Headache—Stavudine—acquired immunodeficiency syndrome	0.00194	0.00504	CcSEcCtD
Amlexanox—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.00503	CcSEcCtD
Amlexanox—Headache—Abacavir—acquired immunodeficiency syndrome	0.00191	0.00497	CcSEcCtD
Amlexanox—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0019	0.00495	CcSEcCtD
Amlexanox—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00189	0.00613	CbGeAlD
Amlexanox—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00188	0.0049	CcSEcCtD
Amlexanox—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00188	0.00488	CcSEcCtD
Amlexanox—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00184	0.0048	CcSEcCtD
Amlexanox—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00184	0.00478	CcSEcCtD
Amlexanox—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00182	0.0059	CbGeAlD
Amlexanox—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00181	0.00471	CcSEcCtD
Amlexanox—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.0047	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.0047	CcSEcCtD
Amlexanox—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00179	0.00465	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00174	0.00452	CcSEcCtD
Amlexanox—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00448	CcSEcCtD
Amlexanox—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.00448	CcSEcCtD
Amlexanox—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.00438	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00166	0.00431	CcSEcCtD
Amlexanox—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00164	0.00427	CcSEcCtD
Amlexanox—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.0016	0.00416	CcSEcCtD
Amlexanox—Headache—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00408	CcSEcCtD
Amlexanox—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00387	CcSEcCtD
Amlexanox—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00385	CcSEcCtD
Amlexanox—PDE4B—brain—acquired immunodeficiency syndrome	0.00145	0.00468	CbGeAlD
Amlexanox—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00369	CcSEcCtD
Amlexanox—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00365	CcSEcCtD
Amlexanox—PDE4B—lymph node—acquired immunodeficiency syndrome	0.0014	0.00453	CbGeAlD
Amlexanox—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00349	CcSEcCtD
Amlexanox—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00341	CcSEcCtD
Amlexanox—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00328	CcSEcCtD
Amlexanox—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00323	CcSEcCtD
Amlexanox—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00313	CcSEcCtD
Amlexanox—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00311	CcSEcCtD
Amlexanox—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00297	CcSEcCtD
Amlexanox—IL3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000629	0.00217	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000604	0.00208	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000604	0.00208	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000595	0.00205	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000592	0.00204	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000591	0.00204	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000591	0.00204	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000588	0.00203	CbGpPWpGaD
Amlexanox—S100A12—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	0.000579	0.00199	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000571	0.00197	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00057	0.00196	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000556	0.00191	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000546	0.00188	CbGpPWpGaD
Amlexanox—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	0.000545	0.00188	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000543	0.00187	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000537	0.00185	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000537	0.00185	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MBL2—acquired immunodeficiency syndrome	0.000533	0.00184	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000529	0.00182	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000523	0.0018	CbGpPWpGaD
Amlexanox—IL3—Immune System—CCR2—acquired immunodeficiency syndrome	0.000522	0.0018	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000515	0.00178	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000502	0.00173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000491	0.00169	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000489	0.00169	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000487	0.00168	CbGpPWpGaD
Amlexanox—S100A12—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000485	0.00167	CbGpPWpGaD
Amlexanox—IL3—Immune System—IFNA1—acquired immunodeficiency syndrome	0.00047	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000464	0.0016	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000457	0.00157	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000456	0.00157	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD79A—acquired immunodeficiency syndrome	0.000456	0.00157	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000454	0.00156	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00045	0.00155	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000443	0.00153	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CCR2—acquired immunodeficiency syndrome	0.000418	0.00144	CbGpPWpGaD
Amlexanox—FGF1—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000416	0.00143	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.00041	0.00141	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000408	0.00141	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000405	0.0014	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000405	0.00139	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events—IL6—acquired immunodeficiency syndrome	0.000404	0.00139	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000403	0.00139	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000402	0.00139	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000401	0.00138	CbGpPWpGaD
Amlexanox—FGF1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000395	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.00039	0.00134	CbGpPWpGaD
Amlexanox—FGF1—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.00039	0.00134	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000387	0.00133	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000387	0.00133	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000379	0.0013	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000379	0.0013	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000376	0.0013	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000373	0.00128	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000372	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000371	0.00128	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00037	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000369	0.00127	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000368	0.00127	CbGpPWpGaD
Amlexanox—IL3—Immune System—CSF2—acquired immunodeficiency syndrome	0.000368	0.00127	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD8A—acquired immunodeficiency syndrome	0.000368	0.00127	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000366	0.00126	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD79A—acquired immunodeficiency syndrome	0.000365	0.00126	CbGpPWpGaD
Amlexanox—IL3—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000354	0.00122	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000352	0.00121	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000351	0.00121	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00035	0.0012	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.00035	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000344	0.00119	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000344	0.00118	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000344	0.00118	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000337	0.00116	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000337	0.00116	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000337	0.00116	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000335	0.00115	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000334	0.00115	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00033	0.00114	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00033	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	0.000324	0.00112	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000321	0.0011	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000321	0.0011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000318	0.0011	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000317	0.00109	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000317	0.00109	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000314	0.00108	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000314	0.00108	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000313	0.00108	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00031	0.00107	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000309	0.00106	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000305	0.00105	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000305	0.00105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000303	0.00104	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000299	0.00103	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000299	0.00103	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000298	0.00103	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000297	0.00102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000297	0.00102	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD8A—acquired immunodeficiency syndrome	0.000295	0.00101	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CSF2—acquired immunodeficiency syndrome	0.000295	0.00101	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.00029	0.001	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00029	0.001	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00029	0.001	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00029	0.000998	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000288	0.000992	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000285	0.000981	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000285	0.000981	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000284	0.000977	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000283	0.000976	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000281	0.000967	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00028	0.000966	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000278	0.000957	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000278	0.000956	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000277	0.000954	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000277	0.000952	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000277	0.000952	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000276	0.000949	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000269	0.000928	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000268	0.000923	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000267	0.000919	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000265	0.000913	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000264	0.000908	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000264	0.000908	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000262	0.000901	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000261	0.000899	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00026	0.000894	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000258	0.000888	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000251	0.000864	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00025	0.000861	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000249	0.000858	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000248	0.000854	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000247	0.000851	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000247	0.00085	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000246	0.000846	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000241	0.000831	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000239	0.000823	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000239	0.000823	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000239	0.000822	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000238	0.000818	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000236	0.000812	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000235	0.00081	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000234	0.000806	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000231	0.000796	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000231	0.000796	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000231	0.000796	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000229	0.000789	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000228	0.000784	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000227	0.000782	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000226	0.000778	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000226	0.000778	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000224	0.000773	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000221	0.000761	CbGpPWpGaD
Amlexanox—IL3—Immune System—IFNG—acquired immunodeficiency syndrome	0.000219	0.000753	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000218	0.000749	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000217	0.000748	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000217	0.000747	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000216	0.000744	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000215	0.000741	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000215	0.000741	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000214	0.000735	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000213	0.000732	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—acquired immunodeficiency syndrome	0.000211	0.000727	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000209	0.000719	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000208	0.000716	CbGpPWpGaD
Amlexanox—FGF1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000207	0.000714	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000205	0.000707	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000205	0.000705	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000203	0.0007	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000203	0.0007	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000201	0.000691	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000199	0.000685	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000198	0.000682	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000198	0.00068	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000195	0.000673	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2—acquired immunodeficiency syndrome	0.000194	0.000669	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000188	0.000648	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000183	0.000631	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000181	0.000622	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000179	0.000617	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000177	0.000609	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000177	0.000609	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IFNG—acquired immunodeficiency syndrome	0.000175	0.000603	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000171	0.000588	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.00017	0.000586	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—acquired immunodeficiency syndrome	0.000169	0.000583	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000168	0.00058	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000168	0.00058	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000168	0.00058	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000168	0.00058	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000166	0.000572	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000166	0.000571	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000162	0.000558	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000159	0.000549	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000157	0.000542	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000157	0.000541	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000156	0.000536	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000156	0.000536	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—acquired immunodeficiency syndrome	0.000156	0.000536	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000155	0.000532	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000154	0.000532	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000152	0.000524	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00015	0.000516	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000145	0.0005	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000145	0.0005	CbGpPWpGaD
Amlexanox—FGF1—Disease—CCR5—acquired immunodeficiency syndrome	0.000142	0.00049	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000139	0.00048	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000136	0.000469	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000135	0.000463	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000133	0.000456	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000131	0.00045	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000128	0.000441	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000126	0.000434	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000126	0.000432	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000125	0.00043	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000124	0.000428	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000121	0.000417	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000119	0.000408	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000119	0.000408	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000117	0.000402	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000115	0.000397	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000115	0.000396	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—acquired immunodeficiency syndrome	0.000114	0.000393	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000113	0.000389	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000111	0.000381	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000109	0.000375	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000107	0.000368	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000104	0.00036	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—acquired immunodeficiency syndrome	0.0001	0.000345	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.96e-05	0.000343	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—acquired immunodeficiency syndrome	9.67e-05	0.000333	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—acquired immunodeficiency syndrome	9.15e-05	0.000315	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—acquired immunodeficiency syndrome	8.98e-05	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—acquired immunodeficiency syndrome	8.93e-05	0.000307	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—acquired immunodeficiency syndrome	8.9e-05	0.000306	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.05e-05	0.000277	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.01e-05	0.000276	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.38e-05	0.000254	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7e-05	0.000241	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.97e-05	0.00024	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.67e-05	0.00023	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.63e-05	0.000228	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.17e-05	0.000212	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.14e-05	0.000211	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.75e-05	0.000198	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—acquired immunodeficiency syndrome	5.23e-05	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—acquired immunodeficiency syndrome	4.83e-05	0.000166	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.73e-05	0.000163	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.12e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.92e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.63e-05	0.000125	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.38e-05	0.000116	CbGpPWpGaD
